Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

BeiGene Ltd. (BGNE)

131.49   -6.75 (-4.88%) 05-17 16:00
Open: 135 Pre. Close: 138.24
High: 137.26 Low: 131.05
Volume: 241,771 Market Cap: 7929M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 137.58 - 138.257 138.257 - 138.807
Low: 129.215 - 130.118 130.118 - 130.849
Close: 130.237 - 131.592 131.592 - 132.691

Technical analysis

as of: 2019-05-17 4:26:59 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 166.19     One year: 194.11
Support: Support1: 125.59    Support2: 115.28
Resistance: Resistance1: 142.29    Resistance2: 166.19
Pivot: 128.04
Moving Average: MA(5): 132.02     MA(20): 126.17
MA(100): 133.47     MA(250): 147.85
MACD: MACD(12,26): 0.48     Signal(9): -1.05
Stochastic oscillator: %K(14,3): 81.09     %D(3): 77.21
RSI: RSI(14): 51.86
52-week: High: 220.10  Low: 105.19  Change(%): -32.4
Average Vol(K): 3-Month: 30504  10-Days: 33940

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
BGNE has closed below upper band by 34.0%. Bollinger Bands are 11.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 01 May 2019 13:11:53 Z
Add Up The Parts: ADRA Could Be Worth $38

Thu, 18 Apr 2019 17:08:30 Z
Oversold Conditions For BeiGene (BGNE)

Thu, 28 Mar 2019 14:08:01 Z
How The Pieces Add Up: ADRA Targets $38

Fri, 22 Mar 2019 21:07:21 Z
3 Key Takeaways From BeiGene's CEO

Fri, 01 Mar 2019 19:13:36 Z
Amicus (FOLD) Reports Wider-than-Expected-Loss for 2018

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 59.80
Shares Float (M) 51.20
% Held by Insiders
% Held by Institutions 94.80
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -12.000
EPS Est. Current Year -3.900
EPS Est. Next Year -4.990
EPS Est. Next Quarter 0.160
Forward EPS -7.070
Book Value (p.s.) 4.250
PEG Ratio -0.34
Profit Margin
Operating Margin -315.68
Return on Assets (ttm) -41.4
Return on Equity (ttm) -56.6
Qtrly Rev. Growth 139.2
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -615.19
Levered Free Cash Flow (M) -532.94

Stock Valuations

P/E -10.96
P/E Growth Ratio -0.05
P/BV 30.94
P/S 1852954624.00
P/CF -12.78

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.